Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 6 | 2021 | 5280 | 0.870 |
Why?
|
Lung Neoplasms | 8 | 2021 | 13196 | 0.830 |
Why?
|
Spheroids, Cellular | 1 | 2021 | 330 | 0.650 |
Why?
|
Dendritic Cells | 3 | 2014 | 2709 | 0.640 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 201 | 0.580 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2019 | 286 | 0.570 |
Why?
|
Carbazoles | 1 | 2018 | 220 | 0.560 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1226 | 0.510 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2020 | 394 | 0.510 |
Why?
|
Interleukin-15 | 1 | 2014 | 181 | 0.450 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2800 | 0.360 |
Why?
|
Receptors, IgG | 1 | 2013 | 566 | 0.350 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2288 | 0.350 |
Why?
|
Piperidines | 1 | 2018 | 1634 | 0.340 |
Why?
|
Thalidomide | 1 | 2015 | 881 | 0.340 |
Why?
|
Interferons | 1 | 2013 | 700 | 0.340 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2013 | 235 | 0.330 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3609 | 0.320 |
Why?
|
Cell Communication | 1 | 2014 | 1628 | 0.290 |
Why?
|
Pyrimidines | 1 | 2018 | 2954 | 0.270 |
Why?
|
Nanoparticles | 2 | 2014 | 1898 | 0.260 |
Why?
|
Vaccines | 1 | 2014 | 817 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 2 | 2020 | 5609 | 0.260 |
Why?
|
Immunotherapy | 1 | 2021 | 4594 | 0.250 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2031 | 0.250 |
Why?
|
MicroRNAs | 1 | 2021 | 3744 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 3984 | 0.240 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5414 | 0.220 |
Why?
|
T-Lymphocytes | 2 | 2015 | 10018 | 0.180 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2023 | 235 | 0.180 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2829 | 0.170 |
Why?
|
Republic of Korea | 1 | 2020 | 531 | 0.160 |
Why?
|
Cisplatin | 1 | 2024 | 1637 | 0.150 |
Why?
|
Exanthema | 1 | 2023 | 500 | 0.150 |
Why?
|
Survival Rate | 3 | 2021 | 12632 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 475 | 0.140 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5101 | 0.140 |
Why?
|
Pleural Neoplasms | 1 | 2021 | 621 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2020 | 1825 | 0.130 |
Why?
|
Organ Specificity | 1 | 2020 | 1949 | 0.130 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 728 | 0.130 |
Why?
|
Thrombomodulin | 1 | 2014 | 103 | 0.110 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2917 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3054 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3166 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4858 | 0.100 |
Why?
|
Humans | 21 | 2024 | 746070 | 0.100 |
Why?
|
Neoplasms | 1 | 2021 | 21681 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1841 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2024 | 9172 | 0.100 |
Why?
|
Middle Aged | 9 | 2024 | 214419 | 0.100 |
Why?
|
NF-kappa B | 1 | 2019 | 2462 | 0.090 |
Why?
|
Lectins, C-Type | 1 | 2014 | 584 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1582 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 2014 | 943 | 0.090 |
Why?
|
Female | 11 | 2024 | 382129 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1585 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2021 | 2793 | 0.090 |
Why?
|
Granuloma, Plasma Cell | 1 | 2011 | 80 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2887 | 0.090 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2136 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4818 | 0.090 |
Why?
|
Signal Transduction | 1 | 2013 | 23115 | 0.090 |
Why?
|
Antigens, Surface | 1 | 2014 | 1607 | 0.090 |
Why?
|
Thyroid Neoplasms | 1 | 2023 | 2294 | 0.090 |
Why?
|
Cohort Studies | 3 | 2024 | 40505 | 0.090 |
Why?
|
Thrombosis | 2 | 2020 | 3000 | 0.080 |
Why?
|
Interferon-alpha | 1 | 2013 | 902 | 0.080 |
Why?
|
Chemokines | 1 | 2013 | 955 | 0.080 |
Why?
|
Prognosis | 4 | 2024 | 29072 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2013 | 653 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2014 | 1240 | 0.080 |
Why?
|
Antigens | 1 | 2014 | 1438 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8830 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2495 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1599 | 0.080 |
Why?
|
Mice | 3 | 2021 | 80065 | 0.070 |
Why?
|
Mutation | 3 | 2023 | 29620 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2024 | 57552 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13302 | 0.070 |
Why?
|
Antibodies | 1 | 2014 | 2408 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1647 | 0.070 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2170 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6300 | 0.060 |
Why?
|
Palliative Care | 1 | 2021 | 3546 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4247 | 0.060 |
Why?
|
Male | 8 | 2024 | 351098 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2820 | 0.060 |
Why?
|
Animals | 5 | 2021 | 166308 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6453 | 0.060 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16652 | 0.060 |
Why?
|
Monocytes | 1 | 2013 | 2544 | 0.060 |
Why?
|
Tissue Donors | 1 | 2013 | 2206 | 0.060 |
Why?
|
Inflammation | 2 | 2020 | 10591 | 0.060 |
Why?
|
Liver Diseases | 1 | 2011 | 1268 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 20812 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3698 | 0.050 |
Why?
|
Aged | 4 | 2024 | 164222 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11037 | 0.050 |
Why?
|
Adult | 5 | 2024 | 214969 | 0.050 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2013 | 2103 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 78293 | 0.050 |
Why?
|
Patient Advocacy | 1 | 2021 | 359 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2014 | 18891 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1848 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39589 | 0.040 |
Why?
|
Catheter Ablation | 1 | 2011 | 2713 | 0.040 |
Why?
|
Hemostasis | 1 | 2020 | 448 | 0.040 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 604 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9313 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11539 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16250 | 0.030 |
Why?
|
Virus Internalization | 1 | 2020 | 488 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 53219 | 0.030 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 741 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 613 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 722 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3245 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 63664 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2030 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 16937 | 0.020 |
Why?
|
Hexuronic Acids | 1 | 2011 | 144 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 2011 | 149 | 0.020 |
Why?
|
Child, Preschool | 1 | 2013 | 41383 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1781 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7116 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8434 | 0.020 |
Why?
|
Alginates | 1 | 2011 | 244 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7199 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1771 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2020 | 4414 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3013 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3118 | 0.020 |
Why?
|
Young Adult | 1 | 2013 | 57114 | 0.020 |
Why?
|
Elasticity Imaging Techniques | 1 | 2011 | 383 | 0.020 |
Why?
|
Dogs | 1 | 2011 | 3820 | 0.020 |
Why?
|
Child | 1 | 2013 | 78469 | 0.020 |
Why?
|
Adolescent | 1 | 2013 | 86212 | 0.020 |
Why?
|
Anticoagulants | 1 | 2020 | 4732 | 0.020 |
Why?
|
Ultrasonography, Interventional | 1 | 2011 | 1478 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 23454 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25174 | 0.010 |
Why?
|
Swine | 1 | 2011 | 5869 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 72413 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 38752 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15306 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 17831 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20145 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35781 | 0.000 |
Why?
|
Concepts
(149)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(72)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_